Immunotherapy for non-muscle-invasive bladder cancer: from the origins of BCG to novel therapies
(2021)
Journal Article
Unsworth-White, S. R., Kitchen, M. O., & Bryan, R. T. (2022). Immunotherapy for non-muscle-invasive bladder cancer: from the origins of BCG to novel therapies. Future Oncology, 18(1), 105-115. https://doi.org/10.2217/fon-2021-0781
Supplies of intravesical Bacillus Calmette-Guérin (BCG), the first-line treatment for most intermediate- and high-risk non-muscle-invasive bladder cancers (NMIBC), have proven unreliable over the past decade. This review considers the evolution of BC... Read More about Immunotherapy for non-muscle-invasive bladder cancer: from the origins of BCG to novel therapies.